JRC News

  1. 12 Jun 2014

    Regional Experts Meeting on Non-proliferation Nuclear Forensics held in Hanoi 3-5 June 2014.

    The meeting on enhancing nuclear forensic capabilities in the South East Asian region, was hosted in Vietnam, co-organized by JRC-ITU.

  2. 12 Jun 2012

    A picture is worth a thousand words. This is the reason why the image shown has been awarded the title of "image of the year" by the Society of Nuclear Medicine (SNM). It comes from a study led by the Joint Research Centre´s (JRC) Institute for Transuranium Elements (ITU) and conducted in collaboration with University Hospital Heidelberg

  3. 1 Dec 2011

    Invasive fungal infections (IFI) are a major threat to individuals with cancer, transplants, HIV, and other conditions that weaken their immune system. New research has shown that radioimmunotherapy (RIT) could be a promising avenue for development of new types of treatment of fungal diseases. The research is published in a paper co-authored by JRC scientists in the framework of collaboration with the Albert Einstein College of Medicine (AECM) in New York.

  4. 20 Jul 2011

    Experts from medicine, biology, chemistry and physics gathered in Berlin on 18 and 19 July for the 7th Symposium on Targeted Alpha Therapy, organised by the JRC's Institute for Transuranium Elements (ITU) and engineering company Eckert & Ziegler Eurotope GmbH.

  5. 22 Oct 2009

    At this year's Annual Congress of the European Association of Nuclear Medicine (EANM 2009), the JRC's work in the field of alpha immunotherapy received special recognition. The presentation by Frank Bruchertseifer of the JRC Institute for Transuranium Elements (ITU) was nominated for the EANM 2009 Marie Curie Award and received the Eckert and Ziegler Award (Top 5 papers presented by young investigators below 38 years of age). The paper describes methods for the production of the alpha emitters Th-226 and Bi-213 and compares their therapeutic efficacy in vitro and in vivo.

  6. 14 Feb 2009

    Today at the annual meeting of the American Association for the Advancement of Science (AAAS) in Chicago, Ekaterina Dadachova of the Albert Einstein College of Medicine in New York gave a topical lecture on "Novel approaches to the therapy of infectious diseases", detailing the results of a joint project with scientists at the JRC Institute for Transuranium Elements (ITU) on the use of alpha-immunotherapy as a new option for the treatment of HIV infections.

  7. 13 Nov 2008

    A joint study involving JRC scientists Frank Bruchertseifer and Alfred Morgenstern from the Institute for Transuranium Elements (ITU) and collaborators from Klinikum Rechts der Isar (KRDI) in Munich has won the 2008 Marie Curie Award of the European Association of Nuclear Medicine.

  8. 30 Nov 2007

    European and American researchers think that radioactive antibodies could be used to treat HIV patients. Researchers from the Albert Einstein College of Medicine, in New York, USA, and the European Commission's Joint Research Centre, in Karlsruhe, Germany, have combined antibodies with radioactive payloads that selectively target and destroy HIV infected cells. The test results are encouraging. They support the hypothesis that radioactive antibodies (Bi-213) can eliminate the immunodeficiency virus HIV from a patient's body. The new HIV treatment will soon be tested in a clinical study conducted on HIV infected patients.